{
    "clinical_study": {
        "@rank": "89116", 
        "acronym": "microRNA-29b", 
        "arm_group": {
            "arm_group_label": "Oral cancer", 
            "description": "Subjects who suffer from oral cancer.\nSubjects must:\nShould have a blood exam (20ml/each time) before the surgery and 3 months after the surgery.\nIn the case the disease recurs after the surgery, subjects need to receive the surgery again and take another blood exam before the surgery and 3 months after the surgery.\nBefore the surgery site staff must:\nCollect subjects' saliva once a day (in the morning before breakfast) for 3 consecutive days.\nCollect a 0.5x0.5Cm2 tissue sample of the tumor during the surgery."
        }, 
        "biospec_descr": {
            "textblock": "tissue, serum, saliva"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The Role of microRNA-29b in the Oral Squamous Cell Carcinoma"
        }, 
        "brief_title": "The Role of microRNA-29b in the Oral Squamous Cell Carcinoma", 
        "condition": "Oral Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Squamous Cell", 
                "Mouth Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "To find out if there is prognostic value which to the performance of microRNA-29b of oral\n      cancer in Taiwan and provide some reference for future treatment.\n\n      We anticipate to enroll 100 persons with oral cancer and collect the tissue which was\n      stained for pathological sections over a 3 year period.\n\n      We also collect the blood and saliva samples from patients and the results along with\n      patient-specific information such as tumor phases, tumor size, lymph node metastasis, cancer\n      metastasis, prognosis and betel nut chewing, smoking and drinking habits and other\n      parameters are statistically analyzed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cancer of the oral cavity.\n\n        Exclusion Criteria:\n\n          -  pregnant woman\n\n          -  refuse the surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Medical center"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009852", 
            "org_study_id": "201309076RIN"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "microRNA-29b", 
            "Oral squamous cell carcinoma", 
            "migration", 
            "prognosis"
        ], 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "contact": {
                "email": "sjcheng56@ntu.edu.tw", 
                "last_name": "Shin-Jung Cheng, 10048", 
                "phone": "+886 2 29251733", 
                "phone_ext": "67509"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan", 
                    "zip": "10048"
                }, 
                "name": "National Taiwan University Hospital research Ethics Committee"
            }, 
            "investigator": {
                "last_name": "Shin-Jung Cheng, DDS, MS, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Role of microRNA-29b in the Oral Squamous Cell Carcinoma", 
        "overall_contact": {
            "email": "sjcheng56@ntu.edu.tw", 
            "last_name": "Shin-Jung Cheng, DDS, MS, PhD", 
            "phone": "+886 2 29251733", 
            "phone_ext": "67509"
        }, 
        "overall_official": {
            "last_name": "Shin-Jung Cheng, DDS, MS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "microRNA-29b", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "reference": [
            {
                "PMID": "15372042", 
                "citation": "Ambros V. The functions of animal microRNAs. Nature. 2004 Sep 16;431(7006):350-5. Review."
            }, 
            {
                "PMID": "17890317", 
                "citation": "Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15805-10. Epub 2007 Sep 21."
            }, 
            {
                "PMID": "19258499", 
                "citation": "Pigazzi M, Manara E, Baron E, Basso G. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res. 2009 Mar 15;69(6):2471-8. doi: 10.1158/0008-5472.CAN-08-3404. Epub 2009 Mar 3."
            }, 
            {
                "PMID": "20173740", 
                "citation": "Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010 Mar;12(3):247-56. doi: 10.1038/ncb2024. Epub 2010 Feb 21."
            }, 
            {
                "PMID": "17898713", 
                "citation": "Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007 Oct 11;449(7163):682-8. Epub 2007 Sep 26. Erratum in: Nature. 2008 Sep 11;455(7210):256."
            }, 
            {
                "PMID": "17113784", 
                "citation": "Huppi K, Volfovsky N, Mackiewicz M, Runfola T, Jones TL, Martin SE, Stephens R, Caplen NJ. MicroRNAs and genomic instability. Semin Cancer Biol. 2007 Feb;17(1):65-73. Epub 2006 Oct 26. Review."
            }, 
            {
                "PMID": "8417385", 
                "citation": "Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993 Jan 21;328(3):184-94. Review. No abstract available."
            }, 
            {
                "PMID": "12778135", 
                "citation": "Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003 Jun;3(6):453-8."
            }, 
            {
                "PMID": "16892035", 
                "citation": "Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006 Aug;12(8):895-904. Review."
            }, 
            {
                "PMID": "17110329", 
                "citation": "Gupta GP, Massagu\u00e9 J. Cancer metastasis: building a framework. Cell. 2006 Nov 17;127(4):679-95. Review."
            }, 
            {
                "PMID": "20511186", 
                "citation": "Scium\u00e8 G, Soriani A, Piccoli M, Frati L, Santoni A, Bernardini G. CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-\u03b21. Neuro Oncol. 2010 Jul;12(7):701-10. doi: 10.1093/neuonc/nop076. Epub 2010 Feb 8."
            }, 
            {
                "PMID": "17070096", 
                "citation": "Kok SH, Hong CY, Lin SK, Lee JJ, Chiang CP, Kuo MY. Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Oral Oncol. 2007 Aug;43(7):639-47. Epub 2006 Oct 25."
            }, 
            {
                "PMID": "12139232", 
                "citation": "Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215. Review."
            }, 
            {
                "PMID": "16849681", 
                "citation": "Chang CC, Lin MT, Lin BR, Jeng YM, Chen ST, Chu CY, Chen RJ, Chang KJ, Yang PC, Kuo ML. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis. J Natl Cancer Inst. 2006 Jul 19;98(14):984-95."
            }, 
            {
                "PMID": "19167326", 
                "citation": "Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215-33. Review."
            }, 
            {
                "PMID": "20728344", 
                "citation": "Erreni M, Solinas G, Brescia P, Osti D, Zunino F, Colombo P, Destro A, Roncalli M, Mantovani A, Draghi R, Levi D, Rodriguez Y Baena R, Gaetani P, Pelicci G, Allavena P. Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer. 2010 Dec;46(18):3383-92. doi: 10.1016/j.ejca.2010.07.022. Epub 2010 Aug 19."
            }, 
            {
                "PMID": "21750716", 
                "citation": "Gaudin F, Nasreddine S, Donnadieu AC, Emilie D, Combadi\u00e8re C, Pr\u00e9vot S, Machelon V, Balabanian K. Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer. PLoS One. 2011;6(7):e21546. doi: 10.1371/journal.pone.0021546. Epub 2011 Jul 7."
            }, 
            {
                "PMID": "10919640", 
                "citation": "Shiraishi K, Fukuda S, Mori T, Matsuda K, Yamaguchi T, Tanikawa C, Ogawa M, Nakamura Y, Arakawa H. Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53. Cancer Res. 2000 Jul 15;60(14):3722-6."
            }, 
            {
                "PMID": "21171082", 
                "citation": "Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF, Fortune F, Tilakaratne WM, Hart IR, Thomas GJ. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol. 2011 Feb;223(3):366-77. doi: 10.1002/path.2786. Epub 2010 Oct 25."
            }, 
            {
                "PMID": "19945376", 
                "citation": "Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009 Nov 25;139(5):871-90. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009852"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Years", 
        "verification_date": "December 2013"
    }
}